Mode
Text Size
Log in / Sign up

Macrophage metabolic reprogramming and polarization may offer therapeutic targets for chronic airway inflammatory diseasesMetabolic Reprogramming May Offer New Path for Airway Inflammation

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that metabolic reprogramming is a key driver of macrophage function in chronic airway inflammatory diseases.

This systematic review explores the mechanisms of macrophage polarization and metabolic reprogramming in the context of chronic upper and lower airway inflammatory diseases, including allergic rhinitis, bronchial asthma, and chronic rhinosinusitis. The review synthesizes evidence regarding how macrophages respond to distinct inflammatory microenvironments.

The authors conclude that macrophages undergo functional polarization in response to these microenvironments, resulting in divergent pro-inflammatory or anti-inflammatory effects. Furthermore, the review identifies metabolic reprogramming as a pivotal mechanism that modulates both the polarization and the overall function of these macrophages.

While the review highlights the potential for targeting metabolic reprogramming to treat chronic airway inflammation, it does not provide specific clinical trial data or evidence of safety and tolerability for any specific intervention. The findings are currently focused on the underlying biological mechanisms rather than established clinical protocols. These findings suggest a potential pathway for future therapeutic development in inflammatory airway diseases.

How this fits prior evidence

This finding addresses a gap in the current evidence by exploring the underlying biological mechanisms of airway inflammation. While prior coverage identified risk factors such as early-life antibiotic use and maternal OCP exposure for allergic rhinitis, and established clinical interventions like CC-SCIT, nasal saline irrigation, and press-needle therapy, this review focuses on the cellular and metabolic drivers of the inflammatory response in allergic rhinitis, bronchial asthma, and chronic rhinosinusitis.

Researchers reviewed how certain immune cells, called macrophages, respond to inflammation in the body. These cells are important in conditions like asthma, allergic rhinitis, and chronic rhinosinusitis. The review found that these cells change their function based on the environment around them, switching between pro-inflammatory and anti-inflammatory roles.

A key finding is that metabolic reprogramming is a major factor in how these cells behave. This means the way these cells process nutrients and energy directly affects how they contribute to inflammation in the airways. By understanding these metabolic pathways, scientists may find new ways to manage chronic respiratory issues.

Because this is a systematic review of biological mechanisms, it does not provide specific clinical trial data or new medications. The results are currently focused on the potential for future treatments. Patients with chronic airway diseases should speak with their doctors about current treatment options and how new research might affect future care.

What this means for you:
Targeting the metabolism of immune cells may offer a future way to treat asthma and chronic sinus conditions.

Common questions

What is the role of macrophages in respiratory issues?

Macrophages are immune cells that react to their environment. In conditions like asthma and chronic rhinosinusitis, these cells can switch between pro-inflammatory and anti-inflammatory roles. This review shows that their behavior is influenced by the specific inflammatory environment in the airways.

How does metabolic reprogramming affect these conditions?

Metabolic reprogramming is a key mechanism that controls how macrophages function. By changing how these cells process energy, it may be possible to influence their role in inflammation. This could potentially lead to new ways to treat chronic upper and lower airway diseases.

Is there a new drug available for these conditions based on this study?

No new drugs were identified in this review. The study focuses on the biological mechanisms of immune cells. While it highlights a potential path for future treatments, it does not provide specific clinical trial data or immediate changes to current medical practices.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Chronic upper and lower airway inflammatory diseases (such as allergic rhinitis, chronic rhinosinusitis, and bronchial asthma) are a group of highly heterogeneous disorders primarily characterized by immune imbalance and persistent inflammation as their core features, which seriously affect patients’ quality of life. As an important component of the immune system, macrophages can undergo functional polarization in response to distinct inflammatory microenvironments, exerting divergent pro-inflammatory or anti-inflammatory effects. They also form intricate interaction networks with other immune cells to jointly regulate the progression of chronic airway inflammation. Although the regulation of macrophage plasticity is regulated by multiple aspects, metabolic reprogramming has emerged as a pivotal mechanism modulating macrophage polarization and function. This review systematically summarizes the interplay between macrophage polarization and other immune cells, focusing on the impact of distinct phenotypes and their regulatory pathways on chronic airway inflammatory diseases. Furthermore, we discuss the therapeutic potential of targeting metabolic reprogramming, providing new insights for the precise treatment of chronic upper and lower airway inflammatory diseases.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.